Published in Haematologica on October 01, 2006
Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica (2010) 1.43
Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer (2013) 1.11
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries. Leukemia (2015) 1.10
Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer (2013) 0.95
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study. Haematologica (2012) 0.93
Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist (2011) 0.92
Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica (2009) 0.88
The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis. J Hematop (2008) 0.85
Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Am J Hematol (2016) 0.85
DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil. Adv Hematol (2012) 0.84
The incidence of myelodysplastic syndromes in Western Greece is increasing. Ann Hematol (2013) 0.82
The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication? Expert Rev Hematol (2013) 0.81
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12. Br J Haematol (2016) 0.80
Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain. Haematologica (2013) 0.79
Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia. Int J Biomed Sci (2013) 0.77
Characterization of Common Chromosomal Translocations and Their Frequencies in Acute Myeloid Leukemia Patients of Northwest Iran. Cell J (2016) 0.75
Ruxolitinib in the treatment of polycythemia vera: patient selection and special considerations. J Blood Med (2016) 0.75
The incidence of acute myeloid leukemia in Calgary, Alberta, Canada: a retrospective cohort study. BMC Public Health (2017) 0.75
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ (2009) 5.79
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol (2011) 4.50
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent. Cancer (2008) 3.06
Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol (2003) 2.59
Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol (2008) 2.38
Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev (2005) 2.24
National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax (2010) 2.21
Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev (2005) 2.03
Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer (2008) 1.89
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer (2006) 1.78
Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol (2009) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut (2011) 1.70
Cancer survival is dependent on season of diagnosis and sunlight exposure. Int J Cancer (2006) 1.64
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res (2010) 1.64
Cancer recording and mortality in the General Practice Research Database and linked cancer registries. Pharmacoepidemiol Drug Saf (2012) 1.62
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. Eur Urol (2007) 1.60
Variation in use of the 2-week referral pathway for suspected cancer: a cross-sectional analysis. Br J Gen Pract (2012) 1.55
Using funnel plots to explore variation in cancer mortality across primary care trusts in South-East England. J Public Health (Oxf) (2008) 1.48
Breast carcinoma survival in Europe and the United States. Cancer (2004) 1.43
Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer (2007) 1.43
Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer (2011) 1.38
Estimating attendance for breast cancer screening in ethnic groups in London. BMC Public Health (2010) 1.35
Ethnicity coding in a regional cancer registry and in Hospital Episode Statistics. BMC Public Health (2006) 1.33
Levels of acute health service use among cancer survivors in the United Kingdom. Eur J Cancer (2011) 1.32
High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol (2013) 1.31
Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29
Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol (2006) 1.29
Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer (2009) 1.27
Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer (2007) 1.23
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading. BJU Int (2007) 1.21
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen (2007) 1.21
Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer (2012) 1.19
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol Biomarkers Prev (2007) 1.15
Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int (2009) 1.14
Colorectal cancer incidence, mortality and survival in South-east England between 1972 and 2001. Eur J Cancer Prev (2007) 1.12
Explaining inequalities in access to treatment in lung cancer. J Eval Clin Pract (2006) 1.06
Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax (2012) 1.06
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer. BJU Int (2009) 1.06
Mortality in relation to early retirement in Denmark: a population-based study. Scand J Public Health (2002) 1.06
Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control (2006) 1.05
A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open (2014) 1.05
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer (2007) 1.05
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA. Head Neck (2003) 1.04
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. Cancer Epidemiol (2012) 1.03
Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer (2011) 1.03
Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol (2011) 1.02
International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol (2007) 1.01
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer (2012) 1.01
Histological subtype of lung cancer in relation to socio-economic deprivation in South East England. BMC Cancer (2008) 1.00
Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open (2012) 0.97
Inequalities in the incidence of cervical cancer in South East England 2001-2005: an investigation of population risk factors. BMC Public Health (2009) 0.97
The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung (2014) 0.95
GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death. Blood (2010) 0.95
Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl (2005) 0.95
Does place of death from cancer vary between ethnic groups in South East England? Palliat Med (2011) 0.93
Differences in breast cancer hormone receptor status in ethnic groups: a London population. Eur J Cancer (2012) 0.93
Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol (2011) 0.93
Hospital volume and survival in oesophagectomy and gastrectomy for cancer. Eur J Cancer (2011) 0.92
Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study. Int J Cancer (2014) 0.92
Trends in the treatment of breast cancer in Southeast England following the introduction of national guidelines. J Public Health (Oxf) (2006) 0.92
Socioeconomic and ethnic inequalities in screen-detected breast cancer in London. J Public Health (Oxf) (2013) 0.91
Social differences in lung cancer management and survival in South East England: a cohort study. BMJ Open (2012) 0.90
Leaving home after cancer in childhood: a measure of social independence in early adulthood. Pediatr Blood Cancer (2006) 0.90
Modelling to estimate future trends in cancer prevalence. Health Care Manag Sci (2011) 0.90
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax (2013) 0.90
Radiotherapy waiting times for women with breast cancer: a population-based cohort study. BMC Cancer (2007) 0.89
The future burden of cancer in London compared with England. J Public Health (Oxf) (2009) 0.88
Mesothelioma incidence projections in South East England. Eur Respir J (2012) 0.87
Certified causes of death in patients with mesothelioma in South East England. BMC Cancer (2009) 0.87
DNA methylation gene-based models indicating independent poor outcome in prostate cancer. BMC Cancer (2014) 0.87
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent. Mod Pathol (2010) 0.86
Rapid assessment of mineral concentration in meadow grasses by near infrared reflectance spectroscopy. Sensors (Basel) (2011) 0.85
Reducing inequalities in lung cancer incidence through smoking policies. Lung Cancer (2011) 0.83
Where do teenagers and young adults receive treatment for cancer? J Public Health (Oxf) (2007) 0.83
Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders. Cancer Prev Res (Phila) (2013) 0.82
International comparisons of the incidence and mortality of sinonasal cancer. Cancer Epidemiol (2013) 0.82
Season of cancer diagnosis exerts distinct effects upon short- and long-term survival. Int J Cancer (2009) 0.82
Trends in the incidence and survival of multiple myeloma in South East England 1985-2004. BMC Cancer (2010) 0.81
[Leishmaniasis isolated to the larynx as cause of chronic laryngitis]. Ugeskr Laeger (2010) 0.81
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively. Int J Cancer (2011) 0.81
Causes of death in men with prostate cancer: an analysis of 50,000 men from the Thames Cancer Registry. BJU Int (2013) 0.81
Cancer in the London prison population, 1986-2005. J Public Health (Oxf) (2010) 0.80
Marriage and divorce among childhood cancer survivors. J Pediatr Hematol Oncol (2011) 0.80
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. Pathology (2010) 0.80
Breast cancer and age in Black and White women in South East England. Int J Cancer (2011) 0.80
Comparison of a specialist haematological malignancy database against a regional cancer registry: case ascertainment and diagnostic accuracy. Br J Haematol (2002) 0.80
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort. Virchows Arch (2010) 0.80
[Minimally invasive surgery for hyperparathyroidism]. Ugeskr Laeger (2010) 0.79
A 13-year follow-up of patients with breast cancer presenting to a District General Hospital breast unit in southeast England. Breast (2005) 0.79
Oral cavity, pharyngeal and salivary gland cancer: disparities in ethnicity-specific incidence among the London population. Oral Oncol (2012) 0.79
Risk of upper aerodigestive tract cancer and type of alcoholic beverage: a European multicenter case-control study. Eur J Epidemiol (2012) 0.79
Improving care for patients with lung cancer in the UK. Thorax (2013) 0.79
Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol (2015) 0.79
Survival of mycosis fungoides in patients in the Southeast of England. Dermatology (2005) 0.79
A case-mix model for monitoring of postoperative mortality after surgery for lung cancer. Lung Cancer (2005) 0.78
The incidence and survival of Waldenström's Macroglobulinaemia in South East England. Leuk Res (2007) 0.77
The prognostic value of interim positron emission tomography scans combined with immunohistochemical data in diffuse large B-cell lymphoma. Haematologica (2005) 0.77